Increased expression of tbc1d10b as a potential prognostic and immunotherapy relevant biomarker in liver hepatocellular carcinoma

HIGHLIGHTS

• who: Li Fan from the Department have published the paper: Increased expression of TBC1D10B as a potential prognostic and immunotherapy relevant biomarker in liver hepatocellular carcinoma, in the Journal: Scientific Reports Scientific Reports
• what: No ethics approval was required for the purpose of this study. To describe the study more clearly, a flow chart was developed to systematically describe the study (Fig 1A). The study has, for the first time, shown that TBC1D10B is overexpressed at mRNA levels in LIHC.
• how: Data were analyzed using the 2u00ad -u0394u0394Ct method.
• future: Considering . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.